Substituted phenyl acetamides and their use as protease...

Details Substituted phenyl acetamides and their use as protease... Substituted phenyl acetamides and their use as protease...

2004-04-01

2009-06-23

Oh, Taylor Victor (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S112000, C546S152000, C549S013000, C549S356000, C564S162000

Reexamination Certificate

active

07550474

ABSTRACT:
Phenyl acetamide compounds are described, including compounds of Formula I:or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R3-R6, R11, B, Y and W are set forth in the specification. The compounds of the invention are potent inhibitors of proteases, especially trypsin-like serine proteases, such as thrombin and factor Xa. Compositions for inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation are described. Other uses of compounds of the invention are as anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage, such as catheters, blood dialysis machines, blood collection syringes and tubes, blood lines and stents. Additionally, the compounds can be detectably labeled and employed for in vivo imaging of thrombi.

REFERENCES:
patent: 4418052 (1983-11-01), Wong
patent: 4499082 (1985-02-01), Shenvi et al.
patent: 4652440 (1987-03-01), Paik et al.
patent: 4727064 (1988-02-01), Pitha
patent: 4764604 (1988-08-01), Muller
patent: 4957939 (1990-09-01), Gries et al.
patent: 4980148 (1990-12-01), Dean
patent: 5011686 (1991-04-01), Pang
patent: 5024829 (1991-06-01), Berger et al.
patent: 5024998 (1991-06-01), Bodor
patent: 5122361 (1992-06-01), Kung et al.
patent: 5466811 (1995-11-01), Alexander
patent: 5656600 (1997-08-01), Abelman et al.
patent: 5786515 (1998-07-01), Dolling et al.
patent: 6521663 (2003-02-01), Pan et al.
patent: 2002/0193398 (2002-12-01), Barrow et al.
patent: 2 164 684 (1996-06-01), None
patent: 0 470 578 (1992-02-01), None
patent: 0 604 022 (1994-06-01), None
patent: 0 761 521 (2000-12-01), None
patent: WO 96/11668 (1996-04-01), None
patent: WO 96/32143 (1996-10-01), None
patent: WO 96/38136 (1996-12-01), None
patent: WO 97/01338 (1997-01-01), None
patent: WO 99/26926 (1999-06-01), None
patent: WO 01/68605 (2001-09-01), None
patent: WO 02/28825 (2002-04-01), None
Ashwood, M.S. et al., “Copper-Mediated Reeaction of 2-Halopyridines with Ethyl Bromodifluoroacetate”,Tetrahedron Letters, 2002, 43, 9271-9273.
Baugh, R.J. et al., “Human Leukocyte Granule Elastase: Rapid Isolation and Characterization”,Biochemistry, 1979, 15(4),836-841.
Bergeron, R.J. et al., “Total Synthesis of (+—)-15-Deoxyspergualin”,J. Org. Chem., 1987, 52, 1700-1703.
Bernatowicz, M.S. et al., “Urethane Protected Derivatives of 1-Guanylpyrazole for the Mild and Efficient Preparation of Guanidines”,Tetrahedron Letters, 1993, 34(21),3389-3392.
Claeson, G., “Synthetic Peptides and Peptidomimetics as Substrates and Inhibitors of Thrombin and Other Proteases in the Blood Coagulation System”,Blood Coagulation and Fibrinolysis, 1994, 5. 411-436.
Clagett-Dame, M et al., “Preparation of an Affinity Chromatography Matrix for the Selective Purfication of the Dopamine D2 Receptor from Bovine Striatal Membranes”,Biochima. Biophysica. Acta, 1989, 986, 271-280.
Couglin, S.R., “Molecular Mechanisms of Thrombin Signaling”,Seminars in Hematology, 1994, 31(4). 270-277.
Cuypers, H.T. et al., “Sulhydryl Content of Bovine Eye Lens Leucine Aminopeptidase”,The Journal of Biological Chemistry1982, 257(12), 7086-7091.
Dalcanale, E. et al., “Selective Oxidation of Aldehydes to Carboxylic Acids with Sodium Chlorite-Hydrogen Peroxide”,J. Org Chem.,1986, 51, 567-569.
de Roos, A. et al., “Myocardial Infarct Sizing and Assessment of Reperfusion by Magnetic Resonance Imaging: A Review”,International Journal of Cardiac. Imaging, 1991, 7, 133-138.
Eto, H. et al., “New Antifungal, 1,2,4-Triazoles with Difluoro(heteroaryl) Methyl Moiety”,Chem Pharm Bull., 2000, 48, 982-990.
Feng, D.M. et al., “Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position”,J. Med Chem, 1997, 40, 3726-3733.
Harker, L.A., “Strategies for Inhibiting the Effects of Thrombin”,Blood Coagulation and Fibrinolysis 5(Suppl 1), 1994, S47-S64.
Khaw, B.A. et al., “Myocardial Infarct Imaging of Antibodies to Canine Cardiac Myosin with Indium-111-Diethylentriamine Pentaacetic Acid”,Science, 1980, 209, 295-297.
Lefkovits, J. et al., “Direct Thrombin Inhibitors in Cardiovascular Medicine”,Circulation, 1994, 90(3), 1522-1536.
Mitsunobu, O., “The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products”,Synthesis, 1981, 1, 1-28.
Powers, W.J.et al., “Indium-III Platelet Scintigraphy in Cerebrovascular Disease”,Neurology, 1982, 32, 938-943.
Sanderson, P.E.J. et al., “Efficacious, Orally Bioavailable Thrombin Inhibitors Based on 3-Aminopyridinone or 3-Aminopyrazinone Acetamide Peptidomimetic Templates”,J. Med Chem, 1998, 41, 4466-4474.
Sato, K. et al., “Synthesis of Alkenyl-and Aryldifluoracetate Using a Copper Complex from Ethyl Bromodifluoracetate”,Chem. Pharm Bull., 1999, 47(7), 1013-1016.
Saulnier, M.G. et al. “An Efficient Method for the Synthesis of Guanidino Prodrugs”,Bioorganic&Medicinal Chemistry Letters, 1994, 4(16), 1985-1990.
Szilagyi, G. et al., “Synthesis and Antihypertensive Activity of Novel 6-Substituted-3-Pyridazinylhydrazones”,European J. Med. Chem., 1984, 19(2), 111-117.
Thakur, M.L. et al, “Indium-III Labeled Platelets: Studies on Preparation and Evaluation of In Vitro and In Vivo Functions”,Thrombosis Research., 1976, 9, 345-357.
Tillyer, R. et al., Efficient Synthesis of α-Chloro Ketones via Reaction of Organometallic Reagents with N-Methoxy-N-Methylchloroacetamide,Synlett, 1996, 225-226.
United States Pharmacopeia/ National Formulary-USP, 1995, United States Pharmacopeial Convention, Inc.; Rockville, Maryland, p. 1636.

Affiliated with

Also associated with

Rating

Substituted phenyl acetamides and their use as protease... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted phenyl acetamides and their use as protease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted phenyl acetamides and their use as protease... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4108109